צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים: renovarobio.com (RENB)

The annual growth of operating sales revenue (TTM) reflects the dynamics of Renovaro Inc. (RENB), where the figure remains at . Growth is driven by a multidisciplinary team of AI researchers motivated by stock options. The biotech's reputation is built on the development of personalized cancer therapies. The current strategic vector is focused on integrating medical software to accelerate clinical trials and early diagnosis.
פילוחי נתונים אנליטיים מרוכזים עבור Renovaro Inc. (RENB)

This indicator reflects the daily change in the annual revenue growth rate over the last twelve months. Analyzing the TTM revenue growth YoY allows an investor to assess the speed of business scaling and identify operational disruptions. Fluctuations in the curve serve as a signal of temporary difficulties rather than a degradation of the model. For Renovaro Inc. (RENB), sales growth confirms the effectiveness of commercializing AI diagnostics developed by a stable core of oncologists and virologists.